Corcept Therapeutics (CORT) Inventory (2012 - 2026)

Corcept Therapeutics has reported Inventory for 15 years, with the latest figure at $13.2 million in Q2 2026.

• Quarterly Inventory rose 7.4% year-over-year to $13.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $13.2 million (up 7.4% YoY) and the FY2025 annual result came in at $12.9 million, up 3.67% from the prior year.
• Inventory advanced to $13.2 million in Q2 2026 per CORT's latest filing, from $12.9 million in the prior quarter.
• Over five years, Inventory peaked at $14.4 million in Q1 2025 and troughed at $5.1 million in Q1 2022.
• A 5-year average of $9.2 million and a median of $7.9 million in 2023 frame the typical range for Inventory.
• The sharpest annual moves came in 2025 and 2026: Inventory jumped 99.83% in 2025, then fell 10.29% in 2026.
• Over 5 years, Inventory stood at $6.1 million in 2022, then rose by 26.72% to $7.7 million in 2023, then surged by 60.57% to $12.4 million in 2024, then climbed by 3.67% to $12.9 million in 2025, then increased by 2.46% to $13.2 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $13.2 million, $12.9 million, and $12.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.